lysergic acid diethylamide has been researched along with sk&f-38393 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Winter, JC | 1 |
| Cheng, CY; Giacomelli, S; Palmery, M; Romanelli, L; Silvestrini, B | 1 |
2 other study(ies) available for lysergic acid diethylamide and sk&f-38393
| Article | Year |
|---|---|
Effects of the phenethylamine derivatives, BL-3912, fenfluramine, and Sch-12679, in rats trained with LSD as a discriminative stimulus.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Benzazepines; DOM 2,5-Dimethoxy-4-Methylamphetamine; Fenfluramine; Lysergic Acid Diethylamide; Phenethylamines; Prejudice; Rats | 1980 |
Lysergic acid diethylamide (LSD) is a partial agonist of D2 dopaminergic receptors and it potentiates dopamine-mediated prolactin secretion in lactotrophs in vitro.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Bromocriptine; Cells, Cultured; Cyproheptadine; Dopamine; Dopamine Agonists; Dopamine Antagonists; Female; Lysergic Acid Diethylamide; Pituitary Gland; Prolactin; Rats; Rats, Wistar; Receptors, Dopamine D2 | 1998 |